This study is being done to learn more about genetic mutations in cancer cells and to find out how the development of new technologies can increase knowledge of these mutations and possibly predict an individual's response to certain treatments.
Study Type
OBSERVATIONAL
Enrollment
35
Scripps Translational Science Institute
La Jolla, California, United States
Determine biomarkers of clinical utility and copy number variants through genetic analysis.
Time frame: four years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.